Page last updated: 2024-10-26

disulfiram and Chagas Disease

disulfiram has been researched along with Chagas Disease in 1 studies

Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Almeida-Silva, J1
Menezes, DS1
Fernandes, JMP1
Almeida, MC1
Vasco-Dos-Santos, DR1
Saraiva, RM1
Viçosa, AL1
Perez, SAC1
Andrade, SG1
Suarez-Fontes, AM1
Vannier-Santos, MA1

Other Studies

1 other study available for disulfiram and Chagas Disease

ArticleYear
The repositioned drugs disulfiram/diethyldithiocarbamate combined to benznidazole: Searching for Chagas disease selective therapy, preventing toxicity and drug resistance.
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Animals; Chagas Disease; Disulfiram; Drug Resistance; Humans; Mice; Nitroimidazoles; Transaminases;

2022